Difficulty: Medium
Average Score: 64%
Practice
Which of the following antidepressants is an unselective MAO blocker and produces extremely long-lasting inhibition of the enzyme?
Correct answer
B
Rationale
In this question, the correct answer is B) Tranylcypramine. Tranylcypramine is an unselective MAO (monoamine oxidase) blocker that produces extremely long-lasting inhibition of the enzyme. MAO inhibitors are a class of antidepressants that work by increasing the levels of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain.
Option A) Moclobemide is a reversible MAO-A inhibitor, not an unselective MAO blocker like Tranylcypramine. Option C) Selegiline is a selective MAO-B inhibitor and is not unselective. Option D) Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and does not inhibit MAO enzymes.
Understanding the different classes of antidepressants and their mechanisms of action is crucial in the field of pharmacology and psychiatry. Knowing the specific characteristics of each medication allows healthcare professionals to make informed decisions when prescribing medications for patients with depression or other mood disorders. It is important to be aware of the potential side effects and drug interactions associated with each class of antidepressants to ensure patient safety and effective treatment outcomes.
Option A) Moclobemide is a reversible MAO-A inhibitor, not an unselective MAO blocker like Tranylcypramine. Option C) Selegiline is a selective MAO-B inhibitor and is not unselective. Option D) Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and does not inhibit MAO enzymes.
Understanding the different classes of antidepressants and their mechanisms of action is crucial in the field of pharmacology and psychiatry. Knowing the specific characteristics of each medication allows healthcare professionals to make informed decisions when prescribing medications for patients with depression or other mood disorders. It is important to be aware of the potential side effects and drug interactions associated with each class of antidepressants to ensure patient safety and effective treatment outcomes.